Tag Archives: Stop

Price transparency can stop health insurers’ gain off patient pain

CEO pay disclosures this spring show what many patient advocates already suspected: Health insurance company executives gained from ordinary people’s 2020 pain. While patients avoided hospitals and doctors’ offices last year for fear of catching COVID-19, health insurers laughed all the way to the bank by paying out far fewer claims. Compensation data filed so… Read More »

Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’

Professor Larry Corey, principal researcher of the AMP studies, speaking at HIVR4P Two years ago, at the HIV Research for Prevention (HIVR4P) conference in Madrid, Professor Lynn Morris of the South African National Institute for Communicable Diseases made a prediction about the AMP (Antibody-Mediated Protection) studies. The two studies are the first large studies using injections every… Read More »